TODAY: Monday 15th March: "In Westminster Hall at 16:30, there is a debate on e-petition 569957 on vaccine passports, which states: "We want the government to commit to not rolling out any e-vaccination status/immunity passport to the British public."
https://t.co/MdK5AxvZ3f

URGENT: UK

12 Prominent Scientists and Doctors to EU Regulators: Address ‘Urgent’ Safety Concerns or Halt COVID Vaccines • Children's Health Defense
https://childrenshealthdefense.org/defender/scientists-doctors-halt-covid-vaccines/?utm_source=twitter&utm_medium=defender

Gene editing is not just for one season, it's for life. We do not know what it will do to people next season, the one after, or in five-ten seasons. Viral vector gene therapy caused leukemia in the past after a few years. Think about it well before you agree. Astrazeneca=viral vector gene therapy: "With the development of a leukaemia-like syndrome in two of the small number of patients that have been cured of a disease by gene therapy, it is timely to contemplate how far this technology has come"
https://t.co/R4YZfe2wwH

Our appearance on @bbcworldservice at 48:20 discussing #VaccinePassports & the petition debate at #Westminster Hall

https://www.bbc.co.uk/sounds/play/w172x2wsj0ly8kc

REMINDER: Ursula von der Leyen & the EU will present a proposal for Digital Green Certificates this coming week.

https://twitter.com/EU_Commission/status/1369682499450904578

Our segment this morning on 'Newsday' with BBC radio World Service.

King, E. (2021, February 2). Vitamin D Reduces Covid-19 Mortality and Serious Illness: An Integrated Approach to Evidence. https://doi.org/10.31219/osf.io/95jsd

NutriXiv Preprints | The Role of Vitamin D deficiency in COVID-19 related deaths in BAME, Obese and Other High-risk Categories
https://osf.io/preprints/nutrixiv/73whx/

Robin, can I please ask you to share and implore everyone to watch and re-share this video like their life depends on it!!
A really really important video ( I asked Howard Steen to cut the German parts from a 5+hour video to leave the English parts last night and he has done an amazing job of it). If people don't realise what's going on and fight back we have no hope. Britain has no hope. CoVID itself is not a problem. It has virtually gone We need to stop focusing on that. And we really need to get people to understand the end game and why believing the CoVID narrative is taking us all down a very dangerous path.

https://lbry.tv/@LongXXvids:c/CA--43-Naomi-Wolf:0

"In this article, we note that human host cells sensitively respond to the spike protein to elicit cell signaling. Thus, it is important to be aware that the spike protein produced by the new COVID-19 vaccines may also affect the host cells. We should monitor the long-term consequences of these vaccines carefully, especially when they are administered to otherwise healthy individuals. Further investigations on the effects of the SARS-CoV-2 spike protein on human cells and appropriate experimental animal models are warranted."

Vaccines | Free Full-Text | SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines | HTML
https://www.mdpi.com/2076-393X/9/1/36/htm

If I can be very explicit in terms of strategy, if you don't want the vaccine passport the first thing you need to do is discredit the vaccines. There are plenty of safety grounds upon which they should be discredited. That is the nail we need to be banging with all our hammers, partially because that is how people will also save their immune systems .

REMINDER: ALL CURRENT VACCINES/GENE EDITING USE THE SARSCOV2 SPIKE PROTEIN

"Vaccines that introduce the spike protein into our body to elicit virus-neutralizing antibodies.. In this article, we note that human host cells sensitively respond to the spike protein to elicit cell signaling. Thus, it is important to be aware that the spike protein produced by the new COVID-19 vaccines may also affect the host cells."

"SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 Vaccines

SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Cells

It was found that the treatment of cultured primary human pulmonary artery smooth muscle cells (SMCs) or human pulmonary artery endothelial cells with the recombinant SARS-CoV-2 spike protein S1 subunit is sufficient to promote cell signaling without the rest of the viral components [21]. Furthermore, our analysis of the postmortem lung tissues of patients who died of COVID-19 has determined that these patients exhibited pulmonary vascular wall thickening, a hallmark of pulmonary arterial hypertension (PAH) [21]. Based on these results, we proposed that the SARS-CoV-2 spike protein (without the rest of the viral components) triggers cell signaling events that may promote pulmonary vascular remodeling and PAH as well as possibly other cardiovascular complications

..Kuba et al. [28] showed that the injection of mice with recombinant SARS-CoV-1 spike protein reduced the ACE2 expression and worsened the acid-induced lung injury. In mice with an acid-induced lung injury, the recombinant SARS-CoV-1 spike protein dramatically increased angiotensin II, and the angiotensin receptor inhibitor losartan attenuated the spike protein-induced enhancement of lung injury [28]. Thus, these in vivo studies demonstrated that the spike protein of SARS-CoV-1 (without the rest of the virus) reduces the ACE2 expression, increases the level of angiotensin II, and exacerbates the lung injury.

The SARS-CoV-2 spike protein without the rest of the viral components has also been shown to activate cell signaling by Patra et al. [29]. The authors reported that the full-length SARS-CoV-2 spike protein expressed by the means of transient transfection, either in the human lung alveolar epithelial cell line A549 or in the human liver epithelial cell line Huh7.5, activated NF-κB and AP-1 transcription factors as well as p38 and ERK mitogen-activated protein kinases, releasing interleukin-6. This cell signaling cascade was found to be triggered by the SARS-CoV-2 spike protein downregulating the ACE2 protein expression, subsequently activating the angiotensin II type 1 receptor [29]. These experiments using transient transfection may reflect the intracellular effects of the spike protein that could be triggered by the RNA- and viral vector-based vaccines.

These results collectively reinforce the idea that human cells are sensitively affected by the extracellular and/or intracellular spike proteins though the activation of cell signal transduction."

https://www.mdpi.com/2076-393X/9/1/36/htm

"RBD Only-Containing SARS-CoV-2 Spike Protein Does Not Elicit Cell Signaling in Human Cells

In contrast to the full-length spike protein [26,29] or the full-length SARS-CoV-2 spike protein S1 subunit [21], we found that the RBD only-containing protein (Figure 1) did not promote cell signaling..

The different effects of the full-length S1 and RBD only-containing proteins may be important considering that BNT162b2 [PFIZER commercially produced and given in phases 2 & 3 & to the public] and many other COVID-19 vaccines express the full-length spike protein, while the BNT162b1 vaccine [PFIZER phase 1] encodes only the RBD region"

Possible actions of the SARS-CoV-2 spike protein.

The SARS-CoV-2 spike protein of the intact virus targets ACE2 of the host cells to facilitate the membrane fusion and the viral entry. The SARS-CoV-2 spike protein also elicits cell signaling in human cells [21,29]. COVID-19 vaccines introduce the spike protein into the human body. In addition to eliciting an immune response that suppresses the viral entry, the spike protein produced by the COVID-19 vaccines may also affect the host cells, possibly triggering adverse events."

"Our laboratory only tested the effects of the SARS-CoV-2 spike protein in lung vascular cells and those implicated in the development of PAH [Pulmonary Arterial Hypertension]. However, this protein may also affect the cells of systemic and coronary vasculatures, eliciting other cardiovascular diseases such as coronary artery disease, systemic hypertension, and stroke. In addition to cardiovascular cells, other cells that express ACE2 have the potential to be affected by the SARS-CoV-2 spike protein, which may cause adverse pathological events. Thus, it is important to consider the possibility that the SARS-CoV-2 spike protein produced by the new COVID-19 vaccines triggers cell signaling events that promote PAH, other cardiovascular complications, and/or complications in other tissues/organs in certain individuals (Figure 3). We will need to monitor carefully the long-term consequences of COVID-19 vaccines that introduce the spike protein into the human body. Furthermore, while human data on the possible long-term consequences of spike protein-based COVID-19 vaccines will not be available soon, it is imperative that appropriate experimental animal models are employed as soon as possible to ensure that the SARS-CoV-2 spike protein does not elicit any signs of the pathogenesis of PAH or any other chronic pathological conditions."

Four years is the timeframe for developing leukaemia from the 💉